Elizabeth Stankevich
- Oncology top 1%
- Immunology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Epidemiology top 10%
- Co-authors
- Israel LowyJohn D. PowderlyIra WollnerDrew M. PardollJulie R. BrahmerCharles G. DrakeJoel PicusAlan J. Korman
- Topics
- Cancer Immunotherapy and Biomarkers (29 papers)CAR-T cell therapy research (18 papers)Nonmelanoma Skin Cancer Studies (14 papers)
- Partner nations
- United StatesSpainAustralia
In The Last Decade
Elizabeth Stankevich
38 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 2.4k
- Immunology 1.3k
- Pulmonary and Respiratory Medicine 665
- Molecular Biology 416
- Epidemiology 337
Countries citing papers authored by Elizabeth Stankevich
This map shows the geographic impact of Elizabeth Stankevich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Stankevich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Stankevich more than expected).
Fields of papers citing papers by Elizabeth Stankevich
This network shows the impact of papers produced by Elizabeth Stankevich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Stankevich. The network helps show where Elizabeth Stankevich may publish in the future.
Co-authorship network of co-authors of Elizabeth Stankevich
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Stankevich. A scholar is included among the top collaborators of Elizabeth Stankevich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Stankevich. Elizabeth Stankevich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 31 | |
| 2 | 2 | |
| 3 | 11 | |
| 4 | 8 | |
| 5 | 50 | |
| 6 | 0 | |
| 7 | 24 | |
| 8 | 3 | |
| 9 | 14 | |
| 10 | 3 | |
| 11 | 3 | |
| 12 | 8 | |
| 13 | 2 | |
| 14 | 10 | |
| 15 | 18 | |
| 16 | 109 | |
| 17 | Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlatesbreakdown → | 2331 |
| 18 | 4 | |
| 19 | 4 | |
| 20 | 1 |
About Elizabeth Stankevich
Elizabeth Stankevich is a scholar working on Oncology, Epidemiology and Immunology, having authored 39 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (29 papers), CAR-T cell therapy research (18 papers) and Nonmelanoma Skin Cancer Studies (14 papers). The work is most often cited by research in Oncology (2.4k citations), Immunology (1.3k citations) and Pulmonary and Respiratory Medicine (665 citations). Elizabeth Stankevich has collaborated with scholars based in United States, Spain and Australia. Frequent co-authors include Israel Lowy, John D. Powderly, Ira Wollner, Drew M. Pardoll, Julie R. Brahmer, Charles G. Drake, Joel Picus, Alan J. Korman, Suzanne L. Topalian and William H. Sharfman. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.